Coagulopathy in surgical management of placenta accreta spectrum

One of the major complications of the placenta accreta spectrum (PAS) is the development of coagulopathy. The detection, prevention and prompt treatment of coagulopathy may be lifesaving. Our objective was to study selected factors associated with coagulopathy in the management of PAS by a well-esta...

Full description

Saved in:
Bibliographic Details
Published in:European journal of obstetrics & gynecology and reproductive biology 2019-06, Vol.237, p.126-130
Main Authors: Shamshirsaz, Alireza A., Fox, Karin A., Erfani, Hadi, Clark, Steven L., Hui, Shiu-Ki, Shamshirsaz, Amir A., Rezaei, Atefeh, Nassr, Ahmed A., Lake, Yasmin N., Teruya, Jun, Belfort, Michael A.
Format: Article
Language:English
Subjects:
Abnormal invasive placenta
Adult
Blood Coagulation Disorders - complications
Blood Loss, Surgical - prevention & control
Coagulopathy
Disseminated intravascular coagulation
Female
Humans
Hysterectomy
Multidisciplinary approach
Placenta Accreta - surgery
Placenta accreta spectrum
Pregnancy
Retrospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:One of the major complications of the placenta accreta spectrum (PAS) is the development of coagulopathy. The detection, prevention and prompt treatment of coagulopathy may be lifesaving. Our objective was to study selected factors associated with coagulopathy in the management of PAS by a well-established multidisciplinary team. This is a retrospective review of all patients with pathologically proven PAS (including placenta accreta, increta or percreta) who underwent surgery by our multidisciplinary team between January 2011 and February 2017. Coagulopathy in this setting was defined as a platelet count of 1.5, and/or fibrinogen
ISSN:0301-2115
1872-7654
DOI:10.1016/j.ejogrb.2019.04.026